α5-deficient mice die early in embryogenesis (Yang et al., 1993). To study the functions of α5 integrin later in mouse embryogenesis and during adult life we generated α5 −/−;+/+ chimeric mice. These animals contain α5-negative and positive cells randomly distributed. Analysis of the chimerism by glucose- 6-phosphate isomerase (GPI) assay revealed that α5 −/− cells contributed to all the tissues analyzed. High contributions were observed in the skeletal muscle. The perinatal survival of the mutant chimeras was lower than for the controls, however the subsequent life span of the survivors was only slightly reduced compared with controls (Taverna et al., 1998). Histological analysis of α5 −/−;+/+ mice from late embryogenesis to adult life revealed an alteration in the skeletal muscle structure resembling a typical muscle dystrophy. Giant fibers, increased numbers of nuclei per fiber with altered position and size, vacuoli and signs of muscle degeneration–regeneration were observed in head, thorax and limb muscles. Electron microscopy showed an increase in the number of mitochondria in some muscle fibers of the mutant mice. Increased apoptosis and immunoreactivity for tenascin-C were observed in mutant muscle fibers. All the alterations were already visible at late stages of embryogenesis. The number of altered muscle fibers varied in different animals and muscles and was often increased in high percentage chimeric animals. Differentiation of α5 −/− ES cells or myoblasts showed that in vitro differentiation into myotubes was achieved normally. However proper adhesion and survival of myoblasts on fibronectin was impaired. Our data suggest that a novel form of muscle dystrophy in mice is α5-integrin-dependent.

The interactions of extracellular matrix (ECM)1 components with each other or with cell surface receptors have an important role in many biological processes such as embryonic development, wound healing, malignant transformation and many others (Hynes, 1990, 1992; Ruoslahti, 1991; Hynes and Lander, 1992; Giancotti and Mainiero, 1994). Cell–ECM interactions are mediated by cell surface receptors called integrins. Integrins are transmembrane glycoproteins which consist of noncovalently linked heterodimers each composed of an α and a β chain (Hynes, 1992).

α5β1 integrin is a specific receptor, which binds to the arginine/glycine/aspartic acid region of one of the most common ECM molecules, fibronectin (FN) (Pytela et al., 1985). α5β1 is involved in many cellular processes including cell proliferation and oncogenic transformation (Plantefaber and Hynes, 1989; Giancotti and Ruoslahti, 1990; Schreiner et al., 1991), cell survival (Varner et al., 1995; Zhang et al., 1995), cell migration (Akiyama et al., 1989; Giancotti and Ruoslahti, 1990), assembly of FN-rich matrices (Fogerty et al., 1990), wound healing (Guo et al., 1991), T cell activation (Shimizu and Shaw, 1991), and gene expression (Werb et al., 1989). It also plays an important role during embryogenesis (Yang et al., 1993). Indeed, the α5 subunit is expressed at high levels during embryogenesis in Xenopus (Whittaker and De Simone, 1993), chicken (Muschler and Horwitz, 1991) and mouse (Goh et al., 1997); its expression is more restricted in adult tissues (Muschler and Horwitz, 1991).

Development of skeletal muscle is a multistep process that starts when the somitic mesoderm differentiates into the dermamyotome. Soon after that, primary myoblasts proliferate and migrate to their peripheral locations where they differentiate into postmitotic multinucleated myotubes, the primary myotubes (primary fusion). The migration of secondary myoblasts that align with the primary myotubes leads to the formation of secondary myotubes (secondary fusion). Finally the myotubes specialize as fast or slow contracting fibers and become striated and innervated (Kelly and Rubinstein, 1994). Several adhesion molecules, integrins, cadherins, and immunoglobulin superfamily members are thought to be involved in myogenesis (Knudsen et al., 1990). The extracellular matrix of skeletal muscle consists of a basal lamina around every myotube and interstitial connective tissue (endomysium) between the fibers. Collagens and fibronectins are abundant in the endomysium whereas the basal lamina contains type IV collagen, laminin, heparan sulfate proteoglycan, entactin (nidogen), and fibronectins (Sanes, 1994). α and β integrin subunits are expressed on skeletal muscle cells at different times and subcellular locations. α1, α3, α5, α6, and αv are highly expressed during muscle development and downregulated after full differentiation (Bronner-Fraser et al., 1992; Duband et al., 1992; Enomoto et al., 1993; McDonald et al., 1995). α7 integrin is abundant through all stages of muscle development (Bao et al., 1993), whereas α4 integrin expression rises during secondary myogenesis then is not expressed anymore (Rosen et al., 1992). αv subunit is concentrated at the costameres and at the myotendinous junction (MTJ); α3 is localized to the MTJ whereas α5 is present in adhesion plaque-like structures along the myotube. α7 is concentrated at the MTJ but can also be detected at the neuromuscular junction and along the sarcolemmal membrane. The β1 subunit is present on myoblasts and on muscle fibers along the entire membrane with maximum concentrations at the MTJ and costameres or Z discs (Bozyczko et al., 1989).

A key question is what are the functions of these various integrins in muscle biology? One way to address this question is via genetic elimination of specific integrins. α5-deficient mice die at approximately day 10 or 11 of gestation (Yang et al., 1993). The null embryos have pronounced defects in posterior trunk and yolk sac mesodermal structures. No somites, a kinky neural tube, and vascular defects are observed in the posterior end. To study the functions of the α5 molecule after day 10 or 11 and in adult animals, we generated α5 −/− embryonic stem (ES) cells and injected them into wild-type (WT) blastocysts to obtain α5 −/−;+/+ chimeric animals. Here we present data on the characterization of these chimeras.

Materials And Methods

Growth, Selection, and Differentiation of ES Cells

ES cells, D3 line (Doetschman et al., 1985), were grown as described previously (George et al., 1993). α5 heterozygous ES cells were obtained as described in Yang et al. (1993). One heterozygous α5 ES cell line, clone 47, was expanded and selected with 4–5 mg/ml G418 (GIBCO BRL, Gaithersburg, MD). After 7–9 d of selection, drug-resistant clones were picked and expanded on feeder cells. Half of the cells from each clone were frozen in 10% DMSO in fetal bovine serum and half were lysed for extraction and analysis of DNA. From three independent selection experiments 5 clones that were null for α5 from Southern blot analysis were obtained (154, 162, 194, 201, and 305). Further Southern blot analysis of one of these clones (154) also showed that the vicinity of the mutated genomic region was not altered during the selection (data not shown). Some heterozygous clones that did not become null after G418 selection were used as control clones (152, 155, 98) as well as D3 wild-type cells and ES cells heterozygous for P and E selectins (Robinson et al., 1997). All these cells had characteristics of wild-type cells.

To generate chimeric mice, ES cells were prepared and injected into C57BL6 blastocysts as described by George et al. (1993) and Bradley et al. (1987). Chimeric progeny were identified by coat color 1 wk after birth. Before and around birth the animals were screened by PCR for the presence of the neo gene and by glucose-6-phosphate isomerase assay (see below). Differentiation of ES cells followed the protocol of Yang et al. (1996). The embryoid bodies were analyzed for muscle differentiation after 15–30 d of culture in a leukemia inhibitory factor–free medium. Differentiated cultures were stained with an antibody against skeletal muscle myosin heavy chain (MY32; Sigma Chemical Co., St. Louis, MO) as described (Yang et al., 1996).

DNA Extraction, Southern Blot, and PCR Analysis

DNA was extracted from ES cells or myoblasts as described in Yang et al. (1996). Southern blot analyses were performed as described in Yang et al. (1993). PCR analysis for the neo gene was performed on tail DNA as described in Taverna et al. (1998).

Glucose-6-Phosphate Isomerase Analysis of Tissue

Glucose-6-phosphate isomerase (GPI) analysis was performed on extracts of different tissues, e.g., limb or pectoral muscle, as described in Yang et al. (1996). Densitometric analysis of the GPI assays was performed using either 1 D-multilane scan or Spot Denso scan of the IS-1000 Digital Imaging System (Alpha Innotech, San Leandro, CA). The percentage of ES cell-derived (129Sv) isoform of GPI was calculated as described in Yang et al. (1996).

Histological Analysis

Pregnant mothers were killed towards the end of pregnancy and embryonic day E16–E18 embryos were analyzed. Embryos, newborns, 1–4 wk-old mice, or several month-old animals were killed in a CO2 chamber, opened ventrally and dorsally, and then the opened carcasses were immersed in 10% formalin (3.7% formaldehyde in phosphate-buffered saline) and kept in fixative until processed. In some cases embryos or newborns were cut transversely into four portions, each portion embedded in mounting medium (OCT compound; Miles Laboratories, Elkhart, Milwaukee, WI) and immediately frozen in liquid nitrogen-cooled isopentane. 6-μm sections were cut. The same freezing procedure was used to generate sections from dissected limb or pectoral muscle of adult mice. Transverse or longitudinal paraffin-embedded or frozen sections were processed for hematoxylin and eosin (H&E) or phosphotungstic acid hematoxylin (PTAH) staining according to the supplier's protocol (Sigma Chemical Co.).

Apoptosis

Apoptotic cells were analyzed in the animals using terminal transferase biotinylated-dUTP nick-end labeling (TUNEL) on paraffin sections from E17 or E18 formalin-fixed embryos as described by Morganbesser et al. (1995). To analyze apoptosis in vitro, myoblasts (see below) were plated on mouse laminin-1 (GIBCO BRL) or FN for 2 h before being trypsinized and resuspended in buffer containing 1 μg/ml annexin-FITC as described by the manufacturer's protocol (Zymed, South San Francisco, CA). After a 10-min incubation, the cells were washed, stained with 1 μg/ml Hoechst 33342, and then mounted on a slide. In five separate fields, both the total number of cells and the number of annexin-positive cells were counted.

Immunohistochemistry

To analyze ECM molecules, 6-μm paraffin-embedded or frozen sections from E18 embryos were used. Frozen sections were also used to analyze the distribution of α5 integrin. Paraffin-embedded sections from overnight formalin-fixed embryos were treated with trypsin (0.1%) for 30 min at room temperature and then stained as described in George et al. (1993). Frozen sections from unfixed embryos were stained with the same protocol except that they were not pretreated with trypsin and the incubations were shortened to 15 min for primary and secondary antibodies. Primary antibodies were used at 1:100 dilution: rabbit polyclonal anti-LM (Sigma Chemical Co.); rabbit polyclonal anti-collagen IV (Becton Dickinson Labware, Franklin Lakes, NJ); rabbit polyclonal anti-entactin (nidogen), a gift of A. Chung (University of Pittsburgh, Pittsburgh, PA); rabbit 24 polyclonal anti-FN (Mautner and Hynes, 1977); rat monoclonal anti–tenascin-C (Sigma Mtn-12; Sigma Chemical Co.); rat monoclonal anti α5 integrin (PharMingen, San Diego, CA). Secondary antibodies were used at 1:200 dilution of FITC-conjugated goat anti–rabbit or anti–rat (Biosource International, Camarillo, CA).

Isolation of Myoblasts

Limb muscles from neonatal chimeric mice (−/−;+/+ or +/−;+/+) were dissociated to isolate pure populations of myoblasts as described in Rando and Blau (1994). Primary cultures were plated on laminin-1–coated dishes and grown in growth medium consisting of Ham's F-10 nutrient mixture (BioWhittaker, Walkersville, MD), 20% fetal bovine serum (FBS) (BioWhittaker), 2.5 ng/ml basic fibroblast growth factor (bFGF) (Promega Corp., Madison, WI), and penicillin (200 U/ml)/streptomycin (200 μg/ml) (GIBCO BRL). ES cell-derived myoblasts were purified by maintaining the cells in G418 (50 μg/ml) for at least 2 wk. To induce differentiation, myoblast cultures were maintained in medium consisting of Dulbecco's modified Eagle's medium supplemented with 2% horse serum and penicillin/streptomycin. For analysis of differentiation of each cell population, the differentiated cultures were fixed with MeOH (−20°C) and stained with Hoechst (1 μg/ml). The fusion index was determined microscopically as the ratio of the number of nuclei in cells with three or more nuclei to the total number of nuclei. 10 random fields in each of three separate cultures were counted at 40× magnification, with each field having between 50 and 100 nuclei.

Retroviral Infection

α5 cDNA was introduced into α5-deficient myoblasts by retroviral-mediated gene transfer (Guan et al., 1990) using a human α5 cDNA insert (Argraves et al., 1987). Retroviral infection of myoblast populations was performed as described previously (Rando and Blau, 1994). To ensure a high level of infection, cells were infected on three successive days, which gives >90% infection (Rando and Blau, 1997). To control for the infection procedure, α5-deficient myoblasts were infected with a retrovirus lacking a cDNA insert. Expression of α5 in retrovirally transduced cells was examined by Western blot analysis (see below).

Cell Adhesion

Cells were plated on 5 μg/ml LM-1, 5 μg/ml FN (both from GIBCO BRL), or collagen type I (100 μg/ml; Sigma Chemical Co.) and allowed to attach for 1 h at 37°C. Unattached cells were removed by washing. Adherence was then assessed by hemacytometer counts of attached cells after trypsinization.

Western Blot Analysis

Myoblasts were lysed in RIPA buffer. Proteins (50 μg) were electrophoresed on 7.5% SDS-PAGE gels under nonreducing conditions then transferred to nitrocellulose membranes (Schleicher & Schuell, Inc., Keene, NH). The membranes were probed with an antibody to α5 integrin (1:5,000; Chemicon, Temecula, CA) followed by a peroxidase-linked donkey anti– rabbit secondary antibody (1:10,000; Amersham Corp., Arlington Heights, IL). The enhanced chemiluminescence (ECL) system was used to visualize the bound secondary antibody.

Results

Generation of Chimeric Mice

ES cells heterozygous for α5 integrin were selected in the presence of high concentrations of G418 (4–5 mg/ml) to obtain homozygous clones. Southern blot analysis indicated that five different α5 −/− ES cell clones were generated (Fig. 1). The five clones were injected into WT C57BL6 blastocysts. Control chimeras were produced by injecting clones heterozygous for α5 integrin or for P and E selectins (Robinson et al., 1997) or WT ES cells (D3) into WT C57BL6 blastocysts. Chimeric animals had both black (from C57BL6) and agouti (from 129Sv-derived ES cells) coat color.

Figure 1

Southern Blot analysis of ES cells for α5 integrin. Clone 152, an α5-heterozygous clone of ES cells; both the wt (6.6-kb) and the mutated (8.4-kb) bands are present. 162, 194, 154, 305, four independent homozygous ES cell clones. Only the mutated band is present.

Figure 1

Southern Blot analysis of ES cells for α5 integrin. Clone 152, an α5-heterozygous clone of ES cells; both the wt (6.6-kb) and the mutated (8.4-kb) bands are present. 162, 194, 154, 305, four independent homozygous ES cell clones. Only the mutated band is present.

For embryos and newborns the chimerism was determined by PCR analysis for the neo gene (Taverna et al., 1998) in combination with a GPI assay for quantitation (Yang et al., 1996). The chimerism in adults was evaluated by the coat color. A representative population of chimeric animals obtained using α5 −/− or control ES cells was the following (Table I): at day 17 or 18 of pregnancy, 56% (76 out of 135) of the C57BL6 blastocysts injected with five independent α5 −/− clones developed as chimeric embryos, whereas only 22% (31 out of 139) of the C57BL blastocysts injected with control ES cells (D3 or α5 +/− clones) developed as chimeric embryos. The number of embryos in uterus (chimeric and nonchimeric) was similar in both kind of injections; therefore the higher number of α5 −/−; +/+ chimeric embryos indicates a better contribution of α5 −/− ES clones in the blastocysts; i.e., the null ES clones are highly competent, more so than the parent and control ES cells, presumably as a result of the subcloning involved in their selection. In contrast, at weaning (4-wk-old animals) 18% (37 out of 205) of α5 −/−;+/+ and 15% (39 out 258) of control chimeras were observed. The marked decrease of α5 −/−;+/+ chimeras from 56% at E17 or E18 to 18% at weaning suggests that not all the chimeras present in uterus or born can survive. Indeed we found that many α5 −/−;+/+ newborn chimeras died within the 24 h after delivery. The lower survival rate for α5-null chimeras suggested requirements for α5 integrin in the perinatal development of certain tissues or organs.

Table I

Generation and Survival of α5 −/−;+/+ Chimeric Mice

CloneBlastocysts injectedChimeras at E17-E18Chimeras at weaning
α5 −/− (5 clones)  135  76 (56%)  — 
α5 ± or D3 (wt)  139  31 (22%)  — 
α5 −/− (5 clones)  205  —  37 (18%) 
α5 ± or D3 (wt)  258  —  39 (15%) 
CloneBlastocysts injectedChimeras at E17-E18Chimeras at weaning
α5 −/− (5 clones)  135  76 (56%)  — 
α5 ± or D3 (wt)  139  31 (22%)  — 
α5 −/− (5 clones)  205  —  37 (18%) 
α5 ± or D3 (wt)  258  —  39 (15%) 

Developmental Capacities of α5-null ES Cells

The chimerism of various tissues was analyzed by GPI assay in adult animals (see Table II). The contribution of 129Sv cells in some organs was lower than expected from coat color in both mutant and control chimeras. This was probably due to a disadvantage of 129Sv cells in specific organs. However the α5-null cells contributed equally as well as did the control ES cells (Table II). We analyzed the populations of mature 129Sv-derived T and B lymphocytes by FACS® analysis and observed equal contributions in mutant and in control chimeras (data not shown). Clone 154 was tested for germ-line transmission of the α5-null allele: germline transmission was obtained from both a male and a female chimera indicating the presence of both α5 −/− sperm and oocytes. We conclude that α5 −/− cells contribute to all tissues analyzed, albeit in somewhat different percentages.

Table II

Percentage Contributions of α5 −/− Cells to Tissues of Chimeric Mice

Chimeras TissuePercentage ES cell contribution to chimeras
Control ES cellsα5 −/− ES cells
12345678910111213
Lung  30  10  10  50  30  10  —  —  —  —  —  —  20 
Liver  10  10  30  50  10  40  —  —  —  —  10  20  15 
Spleen  60  50  30  50  80  50  30  —  —  —  10  50  60 
Kidney  60  50  50  80  30  30  —  —  —  —  20  40  50 
Brain  10  10  —  —  40  30  —  —  —  —  —  —  — 
Gut  50  50  —  —  40  30  40  —  —  —  —  —  — 
Heart  60  10  50  65  50  —  30  —  —  80  10  50  20 
Diaphragm  10  10   5  60  50  50  —  —  —   5  —  40  70 
Limb muscle  90  90  30  80  80  90  90  80  90  80  80  80  80 
Pectoral muscle  90  90  —  80  90  90  —  80  90  80  —  80  80 
Coat color*  95  90  40  98  90  90  95  95  95  90  90  98  95 
Chimeras TissuePercentage ES cell contribution to chimeras
Control ES cellsα5 −/− ES cells
12345678910111213
Lung  30  10  10  50  30  10  —  —  —  —  —  —  20 
Liver  10  10  30  50  10  40  —  —  —  —  10  20  15 
Spleen  60  50  30  50  80  50  30  —  —  —  10  50  60 
Kidney  60  50  50  80  30  30  —  —  —  —  20  40  50 
Brain  10  10  —  —  40  30  —  —  —  —  —  —  — 
Gut  50  50  —  —  40  30  40  —  —  —  —  —  — 
Heart  60  10  50  65  50  —  30  —  —  80  10  50  20 
Diaphragm  10  10   5  60  50  50  —  —  —   5  —  40  70 
Limb muscle  90  90  30  80  80  90  90  80  90  80  80  80  80 
Pectoral muscle  90  90  —  80  90  90  —  80  90  80  —  80  80 
Coat color*  95  90  40  98  90  90  95  95  95  90  90  98  95 
*

 Judged by eye; —, not done.  

Muscle Defects in Animals Chimeric for α5

Histological analysis of E16–E18 embryos, newborns, young, and adult animals revealed no major defects. The chimeras were normal in size, weight, and appearance and showed no obvious defects in behavior (walking, climbing, swimming, or mating). The only defects we detected consistently were structural alterations in skeletal muscles. Approximately 40% of the 150 α5 −/−;+/+ chimeric embryos and newborn animals analyzed showed abnormal skeletal muscles in the head, thorax, or limb (i.e., muscles derived from several different embryonic origins—neural crest, lateral mesoderm, somites). Chimerism varying from 10 to 90% was observed for both α5 −/−;+/+ chimeras and control animals. Embryos with the most noticeable alterations had high chimerism as evaluated by GPI analysis of either the upper portion of the right posterior leg (including cartilage, muscle, and skin) or the dissected limb muscle of that leg. Examples of these alterations are illustrated in Fig. 2. Fig. 2, B and C show transverse sections through the thorax (B) or limb (C) of E18 α5 −/−;+/+ chimeric embryos and they illustrate irregularity in the sizes of the fibers with presence of giant fibers, central nuclei, and vacuoles. Increased collagen deposition between fibers and fiber degeneration were also observed in muscle from E18 α5 −/−;+/+ chimeric embryos (Fig. 2, E and F). Sections of the thoracic muscles of control E18 embryos (Fig. 2, A and D) showed good regularity in the muscle structure and no fiber degeneration or collagen accumulation could be observed. Analysis of α5 −/−;+/+ chimeras in the first month after birth confirmed the presence of muscle degeneration and regeneration in the skeletal muscles. Fig. 2, H and I show examples of degeneration in the head muscles of a 9-d-old chimera. Variability in fiber size, central nuclei, empty spaces in the fibers, and increase of connective tissue (especially evident in Fig. 2,I with PTAH staining) were observed. A control muscle is shown in Fig. 2,G. Signs of muscle degeneration–regeneration were still visible in some adult animals (several months old). Many fibers with central nuclei (Fig. 2,K, limb) ring fibers indicative of fiber degeneration and regeneration (Fig. 2,L, limb) and infiltration of adipose tissue (data not shown) were found in head, thorax, and limb muscles. Control limb muscle is shown in Fig. 2,J. The diaphragms and the heart of α5 −/−;+/+ chimeric mice appeared normal at all stages (data not shown), perhaps because the heart and diaphragm generally showed a lower 129Sv (ES cell) contribution than other muscles for both −/− and control chimeras (Table II). Alternatively, it is possible that mice with a high percentage of α5 −/− cells in the diaphragm are among those that die early. Ultrastructural analysis of limb muscle of E17 embryos revealed an increase in the number of mitochondria in some fibers of mutant chimeric mice (Fig. 3, B and C) compared with control chimeras (Fig. 3 A). It is possible that the fibers with more mitochondria correspond to the giant fibers we observed by histology.

Figure 3

Electron micrographs of limb muscle. Limb muscles from E17 control (A) and α5 −/−;+/+ chimeras (B and C) are shown. An increase in the number of mitochondria is observed in some fibers of the mutant chimeras (B and C). Bar, 500 nm.

Figure 3

Electron micrographs of limb muscle. Limb muscles from E17 control (A) and α5 −/−;+/+ chimeras (B and C) are shown. An increase in the number of mitochondria is observed in some fibers of the mutant chimeras (B and C). Bar, 500 nm.

Figure 2

Morphology of skeletal muscle in α5 −/−;+/+ chimeric mice. (A–C) Transverse sections of muscles from E18 chimeric embryos: (A) control thoracic, (B) mutant thoracic, and (C) mutant limb muscles. Giant fibers, central nuclei, vacuoles, and size variability can be observed in the mutant muscles. (D–F) Longitudinal sections of muscles from E18 chimeric embryos: (D) control thoracic muscle, (E) mutant head, and (F) mutant thorax muscles. Increase of collagen among fibers (E) and degeneration of fibers (F) appear in mutant muscles. (G–I) Transverse sections of head muscle of 9-d-old animals: (G) control and (H and I) mutants. Mutant muscles show a high variability in fiber size, increased connective tissue, central nuclei, and fiber degradation. (J–L) Transverse sections of limb muscle of adults: (J) control and (K and L) mutants. Note the presence of central nuclei (K) and ring fibers (L) in mutant chimeras. D and I are PTAH stained, all others are H&E stained. Bar, 50 μm.

Figure 2

Morphology of skeletal muscle in α5 −/−;+/+ chimeric mice. (A–C) Transverse sections of muscles from E18 chimeric embryos: (A) control thoracic, (B) mutant thoracic, and (C) mutant limb muscles. Giant fibers, central nuclei, vacuoles, and size variability can be observed in the mutant muscles. (D–F) Longitudinal sections of muscles from E18 chimeric embryos: (D) control thoracic muscle, (E) mutant head, and (F) mutant thorax muscles. Increase of collagen among fibers (E) and degeneration of fibers (F) appear in mutant muscles. (G–I) Transverse sections of head muscle of 9-d-old animals: (G) control and (H and I) mutants. Mutant muscles show a high variability in fiber size, increased connective tissue, central nuclei, and fiber degradation. (J–L) Transverse sections of limb muscle of adults: (J) control and (K and L) mutants. Note the presence of central nuclei (K) and ring fibers (L) in mutant chimeras. D and I are PTAH stained, all others are H&E stained. Bar, 50 μm.

The distribution of α5 integrin in mutant and control embryos was investigated by immunohistochemistry. α5 integrin immunoreactivity was found around each muscle fiber and at some MTJ in control animals (Fig. 4, A and B). In mutant embryos a conspicuous decrease of α5 integrin staining was found around many muscle fibers; however, fibers completely negative for α5 were rare (Fig. 4 C) due to the fact that null and wild-type myoblasts fuse together.

Figure 4

α5 integrin expression in muscle. Transverse (A and C) and longitudinal (B) sections of thoracic muscle from E18 control (A and B) and mutant (C) chimeric embryos were stained for α5 integrin. α5 integrin is expressed around the muscle fibers (A) and at the myotendinous junctions (MTJ) in control animals, while it is weakly expressed or missing around some fibers in mutant animals (C). Bar, 50 μm.

Figure 4

α5 integrin expression in muscle. Transverse (A and C) and longitudinal (B) sections of thoracic muscle from E18 control (A and B) and mutant (C) chimeric embryos were stained for α5 integrin. α5 integrin is expressed around the muscle fibers (A) and at the myotendinous junctions (MTJ) in control animals, while it is weakly expressed or missing around some fibers in mutant animals (C). Bar, 50 μm.

The composition of the ECM in the muscles of chimeric mice was analyzed by immunohistochemistry. Fibronectin, the ligand for α5β1 integrin, was present around and between all the fibers of both mutant and control chimeras. No major, consistent differences in intensity were observed between giant- and regularly sized fibers of mutant chimeras (data not shown). The basement membrane components, nidogen (entactin), collagen IV, and laminin-1 were also analyzed and no differences in staining were observed between mutant and control chimeras (data not shown). Expression of tenascin-C (TN-C) has been correlated with muscle regeneration in several muscular dystrophies (Settles et al., 1995). In normal muscle it is present only at the MTJ and on the nerves crossing the muscle (Chiquet and Fambrough, 1984). The analysis of TN-C in E17 or E18 embryos showed an enhanced deposition of TN-C around and between some muscle fibers of α5 −/−; +/+ chimeric embryos compared with controls (Fig. 5 A), suggesting a similar process of degeneration–regeneration as in other myopathies.

Figure 5

Muscle lesion–associated phenotypes: tenascin-C (TN-C) expression and apoptosis. (A) Transverse sections of thoracic muscle from E18 mutant or control chimeric embryos were stained for tenascin-C. Sections from control animals show TN-C staining in the nerve (center) crossing the muscle and at the MTJ (upper left), but the muscle itself is negative. In contrast, tenascin is found distributed around muscle fibers in the mutant embryos and is not restricted to the MTJ. (B) Terminal transferase biotinylated-dUTP nick-end labeling (TUNEL) analysis in transverse sections of thoracic muscles from mutant or control E18 embryos is shown. More apoptotic cells are observed in mutant chimeras. Bars, 50 μm.

Figure 5

Muscle lesion–associated phenotypes: tenascin-C (TN-C) expression and apoptosis. (A) Transverse sections of thoracic muscle from E18 mutant or control chimeric embryos were stained for tenascin-C. Sections from control animals show TN-C staining in the nerve (center) crossing the muscle and at the MTJ (upper left), but the muscle itself is negative. In contrast, tenascin is found distributed around muscle fibers in the mutant embryos and is not restricted to the MTJ. (B) Terminal transferase biotinylated-dUTP nick-end labeling (TUNEL) analysis in transverse sections of thoracic muscles from mutant or control E18 embryos is shown. More apoptotic cells are observed in mutant chimeras. Bars, 50 μm.

In mdx/mdx dystrophic mice, degeneration of fibers is sometimes preceded by apoptosis (Matsuda et al., 1995; Sandri et al., 1995; Tidball et al., 1995). We investigated whether the same is true in α5 −/−;+/+ chimeric mice. Fig. 5,B shows that, although almost no apoptosis was observed in E18 control chimeras, some E18 mutant animals (seven out of 10 chosen at random) showed an increase of apoptotic fibers in various muscles (Fig. 5 B, dark fibers).

Myogenesis In Vitro in the Absence of α5 Integrin (ES Cells and Myoblasts)

Our in vivo data suggest that muscle differentiation can occur even in almost complete absence of α5-positive myoblasts (GPI of the limb ∼95%). However, long-term integrity of the muscle is compromised. We examined the ability of α5-null ES cells to differentiate into myoblasts and myotubes. Three null and two heterozygous (control) ES cell clones were grown in suspension to produce embryoid bodies. The embryoid bodies were then plated on gelatin-coated coverslips to induce differentiation. The differentiated cultures were stained with an antibody against skeletal muscle myosin heavy chain. 42% of the wells (19 out of 45) with α5-null embryoid bodies (all three clones) and 28% of the wells (14 out of 50) with control embryoid bodies stained positively. The degree of differentiation (fusion, myosin expression) appeared similar in control and mutant cultures (Fig. 6 A).

Figure 6

ES cell and myoblast differentiation into myotubes. (A) Differentiated α5 +/− and α5 −/− ES cell cultures were stained for skeletal muscle myosin heavy chain and counterstained with hematoxylin (nuclear staining). In both cultures, multinucleated differentiated myotubes are present. (B) Myotube formation by α5 +/− and α5 −/− myoblasts plated on laminin and maintained in differentiation medium for 5 d. (C) Fusion index was determined for α5 +/− and α5 −/− myoblast cultures after 3 and 5 d in differentiation medium. No significant differences were observed between the two cell populations.

Figure 6

ES cell and myoblast differentiation into myotubes. (A) Differentiated α5 +/− and α5 −/− ES cell cultures were stained for skeletal muscle myosin heavy chain and counterstained with hematoxylin (nuclear staining). In both cultures, multinucleated differentiated myotubes are present. (B) Myotube formation by α5 +/− and α5 −/− myoblasts plated on laminin and maintained in differentiation medium for 5 d. (C) Fusion index was determined for α5 +/− and α5 −/− myoblast cultures after 3 and 5 d in differentiation medium. No significant differences were observed between the two cell populations.

To test further the role of α5 integrin in muscle cell adhesion, growth, differentiation, and survival we isolated primary myoblast cultures from control and mutant chimeric mice. Myoblasts derived from α5-null or heterozygous ES cells were selected by culture in G418. The purity of the cell populations was analyzed by Southern blot analysis (data not shown) (Yang et al., 1993, 1995) and the expression of α5 integrin was analyzed by Western blot analysis (Fig. 7,A). Control (+/−) myoblasts expressed α5 integrin whereas α5-null myoblasts were negative for α5 expression (Fig. 7,A). When maintained in low-serum medium, both control (+/−) and mutant (−/−) myoblasts differentiated into multinucleated myotubes (Fig. 6,B), and the rate and extent of myotube formation was similar in the two populations (Fig. 6,C). Control and α5-deficient myoblasts grown on laminin-1 had similar doubling times (data not shown) and displayed similar morphologies (Fig. 7,B). However, the phenotypes of the two populations were very different when plated on fibronectin, the ligand for the α5β1 integrin receptor. Whereas α5-expressing cells attached and spread readily on fibronectin, α5-deficient cells adhered poorly, showed very little spreading, and displayed a rounded morphology, typical of poor cell– substrate adherence (Fig. 7, B and C). As further evidence that the different substrate requirements were indeed due to α5 deficiency (and not to some other property of the α5-deficient cell population), we restored α5 expression to the α5-deficient cells by retrovirus-mediated gene transfer. A control population of α5-deficient cells was infected with a retrovirus expressing only the neo gene. Expression of α5 in rescued cells (but not in control infected cells) was confirmed by Western blot analysis (Fig. 7,A). The rescued cells appeared to adhere as well to fibronectin as did wild-type cells (Fig. 8, A and B).

Figure 8

Phenotypic rescue of α5-deficient myoblasts by retrovirus-mediated gene transfer of the α5 gene (α5 integrin expression is shown in Fig. 7 A). (A) α5 −/− cells into which α5 has been introduced by retrovirus-mediated gene transfer (α5 −/− (RV- α5)) were plated on fibronectin for 1 h. Unlike the α5 −/− cells (see B), the α5 −/− (RV-α5) cells adhered well to fibronectin and were indistinguishable from the control cells (α5 +/−). (B) Quantitative adhesion assay demonstrates that expression of α5 integrin by retrovirus-mediated gene transfer (α5 −/− (RV- α5) cells) restores normal adhesion to FN in the α5 −/− cells. Infection of α5 −/− cells with a control retrovirus expressing only the neo gene (α5 −/− (RV-neo) cells) did not restore normal adherence.

Figure 8

Phenotypic rescue of α5-deficient myoblasts by retrovirus-mediated gene transfer of the α5 gene (α5 integrin expression is shown in Fig. 7 A). (A) α5 −/− cells into which α5 has been introduced by retrovirus-mediated gene transfer (α5 −/− (RV- α5)) were plated on fibronectin for 1 h. Unlike the α5 −/− cells (see B), the α5 −/− (RV-α5) cells adhered well to fibronectin and were indistinguishable from the control cells (α5 +/−). (B) Quantitative adhesion assay demonstrates that expression of α5 integrin by retrovirus-mediated gene transfer (α5 −/− (RV- α5) cells) restores normal adhesion to FN in the α5 −/− cells. Infection of α5 −/− cells with a control retrovirus expressing only the neo gene (α5 −/− (RV-neo) cells) did not restore normal adherence.

Figure 7

Myoblast adhesion on different substrates. (A) Western blot analysis of α5 integrin expression in different cell populations. RV, retrovirus-mediated gene transfer. (B) Morphology of α5 +/− and α5 −/− cells plated on laminin or fibronectin for 1 h. On fibronectin, α5 −/− cells displayed a rounded morphology indicative of poor adherence. (C) Relative adhesion of α5 −/− and α5 +/− myoblasts plated on different substrates for 1 h. Data are presented as mean ± SD from four separate experiments, each performed in duplicate.

Figure 7

Myoblast adhesion on different substrates. (A) Western blot analysis of α5 integrin expression in different cell populations. RV, retrovirus-mediated gene transfer. (B) Morphology of α5 +/− and α5 −/− cells plated on laminin or fibronectin for 1 h. On fibronectin, α5 −/− cells displayed a rounded morphology indicative of poor adherence. (C) Relative adhesion of α5 −/− and α5 +/− myoblasts plated on different substrates for 1 h. Data are presented as mean ± SD from four separate experiments, each performed in duplicate.

Because of the apoptosis we observed in vivo (Fig. 5,B) and since interference with integrin-mediated adhesion has been reported to cause apoptosis (Frisch and Francis, 1994; Zhang et al., 1995; Goh et al., 1997), we tested for apoptosis in the myoblasts cultured on various substrates. Whereas α5-expressing cells showed similar percentages of annexin-positive cells on fibronectin or laminin-1, α5-deficient cells showed a fourfold increase in annexin-positive cells on fibronectin compared with laminin-1 (Fig. 9). Clearly, the absence of α5 expression increases the propensity of the cells to undergo apoptotic cell death when FN is the major component of the ECM.

Figure 9

Myoblast survival on fibronectin versus laminin. Apoptosis in α5 +/−, α5 −/−, and α5 −/− (RV-α5) cells plated on FN or LM was determined by annexin staining (see Materials and Methods). Data are presented as percentages of apoptotic cells on FN compared with that on LM for each cell type. Whereas the percentage of apoptosis in α5 +/− and α5 −/− (RV-α5) were similar on the two substrates, there was increased apoptosis of α5 −/− cells on fibronectin compared with laminin.

Figure 9

Myoblast survival on fibronectin versus laminin. Apoptosis in α5 +/−, α5 −/−, and α5 −/− (RV-α5) cells plated on FN or LM was determined by annexin staining (see Materials and Methods). Data are presented as percentages of apoptotic cells on FN compared with that on LM for each cell type. Whereas the percentage of apoptosis in α5 +/− and α5 −/− (RV-α5) were similar on the two substrates, there was increased apoptosis of α5 −/− cells on fibronectin compared with laminin.

Discussion

The results presented here show that α5-null cells can participate in a wide variety of differentiative processes; animals with a high degree of chimerism in many organs survive and reproduce. The only defect which we observed consistently in chimeric animals containing a significant proportion of α5-null cells was a novel form of muscular dystrophy. This allowed us to focus on the differentiation and survival of muscle cells and tissues and the dependence of these processes on α5β1 integrin.

Earlier results have shown blockade of migration of myoblasts and of their differentiation into myotubes by inhibitory antibodies against various integrin subunits, including β1 (Jaffredo et al., 1988; Menko et al., 1987), α4 (Rosen et al., 1992) or α7 (Echtermeyer et al., 1996; Yao et al., 1996). However, in vitro differentiation of ES cells and myoblasts lacking β1 or α4 proceeds normally (Yang et al., 1996; Brakebush et al., 1997) and β1-null and α4-null cells can participate in myogenesis in chimeric mice (Faessler and Meyer, 1995; Yang et al., 1996). In the experiments reported here, we obtained similar results for α5-null cells. In vitro, neither α5-null ES cells nor α5-null myoblasts showed any deficit in myogenesis and, in chimeric mice, muscles with a high proportion of α5-null cells could form. These results demonstrate that α5β1 integrin is not essential for the proliferation, migration, or differentiation of myoblasts, myotubes, and skeletal muscles. However, in contrast with the results for α4-null chimeras (Yang et al., 1996), we observed a significant level of abnormalities in the skeletal muscles of the α5-null chimeras (Figs. 24). These muscles showed many characteristics of muscular dystrophy, including giant fibers, central nuclei, vacuoles, fibrosis, and fiber degeneration. Later in life we observed signs of regeneration such as ring fibers. We also observed increased apoptosis and ectopic expression of TN-C (Fig. 5) as has been reported for other forms of muscular dystrophy (Settles et al., 1996).

These results are reminiscent of the observations of Mayer et al. (1997) on α7 integrin-deficient mice, which also exhibit muscular dystrophy, and of recent reports of deficiencies in α7β1 in human and murine muscular dystrophies (Hodges et al., 1997; Mayer et al., 1997; Vachon et al., 1997). It appears that these two integrins, α5β1 and α7β1, one a receptor for fibronectin and the other a receptor for laminin, are both necessary for long-term integrity of myotubes, although not for their initial development.

α5 is found localized at adhesion plaques (McDonald et al., 1995) and at the MTJ (Fig. 4); α7 is concentrated at the MTJ (McDonald et al., 1995) where tendons attach. Because these two integrins are present at the points in the fibers where mechanical stress occurs, it suggests an anchoring function of these molecules. Two Drosophila mutants show a similar situation; in myospheroid and inflated (mutations affecting integrin subunits) muscle differentiation occurs in the absence, respectively, of βPS or αPS2 integrins; however, on contraction, the muscles detach from their attachments (Volk et al., 1990; Brabant et al., 1993). We can imagine that, in the absence of α7β1 or α5β1, important points of adhesion are lost or weakened and therefore contraction leads to damage to the myotubes. The increase in the number of mitochondria in some fibers of the α5 −/−;+/+ chimeric mice could suggest that, when the fibers cannot function normally, they tend to hypercontract and they need more ATP that requires the formation of a higher number of mitochondria. Other possibilities for the increase in mitochondria include altered differentiation and compensation for the reduced level of α5 integrin.

It is noteworthy that many forms of muscular dystrophy arise from defects in connections to the extracellular matrix. That includes the classical muscular dystrophies arising from defects in dystrophin and its transmembrane linkage via dystroglycans to laminins and in the laminins themselves (Campbell, 1995). The novel form of muscular dystrophy which we describe here differs from the others, including those caused by α7 integrin deficiencies, in having no obvious connection with laminins. α5β1 has no affinity for laminins and is believed to be specific for fibronectin. The α5-null myoblasts show defects in adherence and survival on fibronectin substrates but behave normally on laminin (Fig. 7).

The fact that the muscle defect of the α5-chimeric mice is visible at a very early age (embryonic and postnatal life) and is more attenuated later in life might be due to the high expression, and probable importance, of α5 in embryonic and postnatal muscle followed by later downregulation (McDonald et al., 1995). In vitro data show that overexpression of α5β1 in myoblasts promotes proliferation and inhibits differentiation, suggesting a proliferative function of this integrin (Sastry et al., 1996). It is possible that, in the chimeras, α5 is particularly important when a high rate of proliferation is occurring. However, since our mice are chimeras and the muscle fiber is a fusion of α5-null and wild-type cells we cannot exclude the possibility that the defect is partially rescued by the presence of wild-type cells. Another possible reason for amelioration of the phenotype in later life could be gradual replacement of α5-null cells by wild type during regeneration. Consistent with this possibility is the appearance of ring fibers in the older muscles, indicating some fiber regeneration.

We favor the hypothesis that the dystrophy arises from defects in the myofibers themselves, as discussed above. In particular, the time of onset during fetal life corresponds with the period when α5β1 is known to be strongly expressed in muscle cells and the parallels with the muscle defects seen in Drosophila integrin mutants are suggestive. However, we cannot rule out the possibility that defects or deficits in other α5-null cells, such as interstitial fibroblasts, neurons or Schwann cells or vascular endothelial cells, could contribute to the phenotype observed. We do know that α5-null fibroblasts can assemble FN matrix and migrate and adhere normally (Yang and Hynes, 1996) and proliferate normally in vitro (Goh, K.L., and R.O Hynes, unpublished data) which argues against a causal defect in fibroblasts without eliminating that possibility.

The reasons for the degenerative changes observed in the muscles deficient in α5β1 remain unclear, as indeed is the case for other muscular dystrophies. Several possible explanations can be imagined. As mentioned above, if α5β1 (and α7β1) are important for maintaining mechanical connections between the myotubes and adjacent structures (e.g., tendons), disruption of the weakened linkage under contraction is a likely initiating cause. Perhaps less likely in this case is a general weakening of the cell surface structure comprising submembranous cytoskeleton connected to the basal lamina. Another possibility is that the apoptosis (Fig. 5) could be a causative event rather than a secondary consequence. Precedent exists for cells' being dependent on specific integrin-matrix adherence for cell survival (Zhang et al., 1995) and such dependences include dependence on α5β1–fibronectin interactions (Zhang et al., 1995). However, our in vitro data somewhat argue against this idea without ruling it out. The α5-null myoblasts do indeed show increased apoptosis when plated on fibronectin but do not when plated on laminin (Fig. 9). Myotubes are surrounded by a basal lamina rich in laminin, although also containing fibronectin. Thus, although it is possible that adherence to fibronectin via α5β1 is specifically necessary for myotube survival, it seems more likely that any such requirement for attachment to basal lamina is satisfied by connection to laminin via α7β1 or via dystroglycans. Whatever the detailed cause–effect relationships leading to fiber degeneration and muscular defects in the mice, the results reported here reveal a novel form of muscular dystrophy.

Abbreviations used in this paper

     
  • ECM

    extracellular matrix

  •  
  • ES

    embryonic stem

  •  
  • FN

    fibronectin

  •  
  • GPI

    glucose-6-phosphate isomerase

  •  
  • H&E

    hematoxylin and eosin

  •  
  • LM

    laminin

  •  
  • MTJ

    myotendinous junction

  •  
  • PTAH

    phosphotungstic acid haematoxylin

  •  
  • TN-C

    tenascin-C

  •  
  • WT

    wild-type

References

References
Akiyaa
SK
,
Yamad
SS
,
Chen
WT
,
Yamada
K
Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration matrix assembly, and cytoskeletal organization
J Cell Biol
1989
109
863
875
[PubMed]
Argraves
WS
,
Suzuki
S
,
Arai
H
,
Thompson
K
,
Pierschbacher
MD
,
Ruoslahti
E
Amino acid sequence of the human fibronectin receptor
J Cell Biol
1987
105
1183
1190
[PubMed]
Bao
ZZ
,
Lakonishok
M
,
Kaufman
S
,
Horwitz
AF
α7β1 integrin is a component of the myotendinous junction on skeletal muscle
J Cell Sci
1993
106
579
589
[PubMed]
Bozyczko
D
,
Decker
C
,
Muschler
J
,
Horwitz
AF
Integrin on developing and adult skeletal muscle
Exp Cell Res
1989
183
72
91
[PubMed]
Brabant
MC
,
Brower
DL
PS2 integrin requirements in Drosophilaembryo and wing morphogenesis
Dev Biol
1993
157
49
59
[PubMed]
Bradley, A. 1987. Production and analysis of chimeric mice. In Teratocarcinomas and Embyonic Stem Cells: A Practical Approach. E.J. Robertson, editor. IRL Press, Oxford, UK. 113–151.
Brakebusch
C
,
Hirsch
E
,
Potocnik
A
,
Faessler
R
Genetic analysis of β1 integrin function: confirmed, new and revised roles for a crucial family of cell adhesion molecules
J Cell Sci
1997
110
2895
2904
[PubMed]
Bronner-Fraser
M
,
Artinger
M
,
Muschler
J
,
Horwitz
AF
Developmentally regulated expression of α6 integrin in avian embryos
Development (Camb)
1992
115
197
211
[PubMed]
Campbell
KP
Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage
Cell
1995
80
675
679
[PubMed]
Chiquet
M
,
Fambrough
DM
Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis
J Cell Biol
1984
98
1926
1936
[PubMed]
Doetschman
TC
,
Eistetter
H
,
Katz
M
,
Schmidt
W
,
Kemler
R
The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium
J Embryol Exp Morphol
1985
87
27
45
[PubMed]
Duband
JL
,
Belkin
AM
,
Syfrig
J
,
Thiery
JP
,
Koteliansky
VE
Expression of α1 integrin, a laminin-collagen receptor, during myogenesis and neurogenesis in the avian embryo
Development (Camb)
1992
116
585
600
[PubMed]
Echtermeyer
F
,
Schoeber
S
,
Poeschl
E
,
von der Mark
H
,
von der Mark
K
Specific induction of cell motility on laminin by α7 integrin
J Biol Chem
1996
271
2071
2075
[PubMed]
Enomoto
MI
,
Boettinger
D
,
Menko
AS
α5 integrin is a critical component of adhesion plaques in myogenesis
Dev Biol
1993
155
180
197
[PubMed]
Faessler
R
,
Meyer
M
Consequences of the lack of β1 integrin gene expression in mice
Genes Dev
1995
9
1896
1908
[PubMed]
Fogerty
FJ
,
Akiyama
SK
,
Yamada
KM
,
Mosher
DF
Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (α5β1) antibodies
J Cell Biol
1990
111
699
708
[PubMed]
Frisch
SM
,
Francis
H
Disruption of epithelial cell matrix interactions induces apoptosis
J Cell Biol
1994
124
619
626
[PubMed]
George
EL
,
Georges
EN
,
Patel-King
RS
,
Rayburn
H
,
Hynes
RO
Defects in mesodermal migration and vascular development in fibronectin-deficient mice
Development (Camb)
1993
119
1079
1091
[PubMed]
Giancotti
FG
,
Mainiero
F
Integrin-mediated adhesion and signaling in tumorigenesis
Biochim Biophys Acta
1994
1198
47
64
[PubMed]
Giancotti
FG
,
Ruoslahti
E
Elevated levels of the α5β1 fibronectin receptor suppress the transformed phenotype of chinese hamster ovary cells
Cell
1990
60
849
859
[PubMed]
Goh
KL
,
Yang
JT
,
Hynes
RO
Mesodermal defects and cranial neural crest apoptosis in α5 integrin-null embryos
Development (Camb)
1997
124
4309
4319
[PubMed]
Guan
JL
,
Trevithick
JE
,
Hynes
RO
Retroviral expression of alternatively spliced forms of rat fibronectin
J Cell Biol
1990
110
833
847
[PubMed]
Guo
M
,
Kim
LT
,
Akiyama
SK
,
Gralnick
HR
,
Yamada
KM
,
Grinnel
F
Altered processing of integrin receptors during keratinocyte activation
Exp Cell Res
1991
195
315
322
[PubMed]
Hodges
BL
,
Hayashi
YK
,
Nonaka
I
,
Wang
W
,
Arahata
K
,
Kaufman
SJ
Altered expression of the α7β1 integrin in human and murine muscular dystrophies
J Cell Sci
1997
110
2873
2881
[PubMed]
Hynes, R.O. 1990. Fibronectin. Springer-Verlag, New York. 546 pp.
Hynes
RO
Integrins: versatility, modulation and signaling in cell adhesion
Cell
1992
69
11
25
[PubMed]
Hynes
RO
,
Lander
AD
Contact and adhesive specificities in the associations, migrations and targeting of cells and axons
Cell
1992
68
303
322
[PubMed]
Jaffredo
T
,
Horwitz
AF
,
Buck
CA
,
Rong
PM
,
Dieterlen-Lievre
F
Myoblast migration specifically inhibited in the chick embryo by grafted CSAT hybridoma cells secreting an anti-integrin antibody
Development (Camb)
1988
103
431
446
[PubMed]
Kelly, A.M., and N.A. Rubinstein. 1994. The diversity of muscle fiber types and its origin during development. In Myology. A.G. Engel and C. Franzini-Armstrong, editors. McGraw-Hill, New York. 119–133.
Knudsen
KA
Cell adhesion molecules in myogenesis
Curr Opin Cell Biol
1990
2
902
906
[PubMed]
Matsuda
R
,
Nishikawa
A
,
Tanaka
H
Visualization of dystrophic muscle fibers in Mdx mouse by vital staining with evans blue: evidence of apoptosis in dystrophin-deficient muscle
J Biochem
1995
118
959
964
[PubMed]
Mautner
V
,
Hynes
RO
Surface distribution of lets protein in relation to the cytoskeleton of normal and transformed cells
J Cell Biol
1977
75
743
768
[PubMed]
Mayer
U
,
Saher
G
,
Faessler
R
,
Bornemann
A
,
Echtermeyer
F
,
von der Mark
H
,
Miosge
N
,
Poeschl
E
,
von der Mark
K
Absence of integrin α7 causes a novel form of muscular dystrophy
Nat Genet
1997
17
318
323
[PubMed]
McDonald
KA
,
Lakonishok
M
,
Horwitz
AF
αv and α3 myofibrillogenesis
J Cell Sci
1995
108
2573
2581
[PubMed]
Menko
AS
,
Boettiger
D
Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation
Cell
1987
51
51
57
[PubMed]
Morgenbesser
SD
,
Schreiber-Agus
N
,
Bidder
M
,
Mahon
KA
,
Overbeek
PA
,
Horner
J
,
DePinho
RA
Contrasting roles for c-myc and L-myc in the regulation of cellular growth and differentiation in vivo
EMBO (Eur Mol Biol Organ) J
1995
14
743
796
[PubMed]
Muschler
JL
,
Horwitz
AF
Down regulation of the chicken α5β1 integrin fibronectin receptor during development
Development (Camb)
1991
113
327
337
[PubMed]
Plantefaber
LC
,
Hynes
RO
Changes in integrin receptors on oncogenically transformed cells
Cell
1989
56
281
290
[PubMed]
Pytela
R
,
Piershbacher
MD
,
Ruoslahti
E
Identification and isolation of a 140 Kd cell surface glycoprotein with properties expected of a fibronectin receptor
Cell
1994
40
191
198
[PubMed]
Rando
TA
,
Blau
HM
Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy
J Cell Biol
1994
125
1275
1284
[PubMed]
Rando
TA
,
Blau
HM
Methods for myoblast transplantation
Methods Cell Biol
1997
52
261
272
[PubMed]
Robinson
SD
,
Frenette
PS
,
Rayburn
H
,
Cummiskey
M
,
Ullman-Culleré
M
,
Wagner
DD
,
Hynes
RO
Generation of double- and triple-deficient selectin mice
Microcirculation
1997
4
131
Rosen
GD
,
Sanes
JR
,
LaChance
R
,
Cunningham
JM
,
Roman
J
,
Dean
DC
Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis
Cell
1992
69
1107
1119
[PubMed]
Ruoslahti
E
Integrins
J Clin Invest
1991
87
1
5
[PubMed]
Sandri
M
,
Carraro
U
,
Podhorska-Okolov
M
,
Rizzi
C
,
Arslan
P
,
Monti
D
,
Franceschi
C
Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise
FEBS Lett
1995
373
291
295
[PubMed]
Sanes, J.R. 1994. The extracellular matrix. In Myology. A.G. Engel and C. Franzini-Armstrong, editors. McGraw-Hill, New York. 242–260.
Sastry
SK
,
Lakonishok
M
,
Thomas
DA
,
Muschler
J
,
Horwitz
AF
Integrin α subunit ratios, cytoplasmic domains and growth factor synergy regulate muscle proliferation and differentiation
J Cell Biol
1996
133
169
184
[PubMed]
Schreiner
C
,
Fisher
M
,
Hussein
S
,
Juliano
RL
Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants
Cancer Res
1991
51
1738
1740
[PubMed]
Settles
DL
,
Cihak
RA
,
Erickson
HP
Tenascin-C expression in dystrophin-related muscular dystrophy
Muscle Nerve
1996
19
147
154
[PubMed]
Shimizu
Y
,
Shaw
S
Lymphocyte interactions with extracellular matrix
FASEB (Fed Am Soc Exp Biol) J
1991
5
2292
2299
[PubMed]
Taverna
D
,
Ullman-Cullerè
M
,
Rayburn
H
,
Bronson
RT
,
Hynes
RO
A test of the role of α5 integrin/fibronectin interactions in tumorigenesis
Cancer Res
1998
58
848
853
[PubMed]
Tidball
JG
,
Albrecht
DE
,
Lokensgard
BE
,
Spenser
ML
Apoptosis precedes necrosis of dystrophin-deficient muscle
J Cell Sci
1995
108
2197
2204
[PubMed]
Vachon
PH
,
Xu
H
,
Liu
L
,
Loechel
F
,
Hayashi
Y
,
Arahata
K
,
Reed
JC
,
Wewer
UM
,
Engvall
E
Integrins (α7β1) in muscle function and survival
J Clin Invest
1995
100
1870
1881
[PubMed]
Varner
JA
,
Emerson
DA
,
Juliano
RL
Integrin α5β1 expression negatively regulates growth: reversal by attachment to fibronectin
Mol Biol Cell
1995
6
725
740
[PubMed]
Volk
T
,
Fessler
LI
,
Fessler
JH
A role for integrin in the formation of sarcomeric cytoarchitecture
Cell
1990
63
525
536
[PubMed]
Werb
Z
,
Tremble
PM
,
Behrendtsen
O
,
Crowley
E
,
Damsky
CH
Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression
J Cell Biol
1989
109
877
889
[PubMed]
Whittaker
CA
,
DeSimone
DW
Integrin α subunit mRNAs are differentially expressed in early Xenopusembryos
Development (Camb)
1993
117
1239
1249
[PubMed]
Yang
JT
,
Hynes
RO
Fibronectin receptor functions in embryonic cells deficient in α5β1 integrin can be replaced by αv integrins
Mol Biol Cell
1996
7
1737
1748
[PubMed]
Yang
JT
,
Rayburn
H
,
Hynes
RO
Embryonic mesodermal defects in α5 integrin-deficient mice
Development (Camb)
1993
119
1093
1105
[PubMed]
Yang
JT
,
Rando
TA
,
Mohler
WA
,
Rayburn
H
,
Blau
HM
,
Hynes
RO
Genetic analysis of α4 integrin functions in the development of mouse skeletal muscle
J Cell Biol
1996
135
829
835
[PubMed]
Yao
CC
,
Ziober
BL
,
Squillace
RM
,
Kramer
RH
α7 integrin mediates cell adhesion and migration on specific laminin isoforms
J Biol Chem
1996
271
25598
25603
[PubMed]
Zhang
Z
,
Vuori
K
,
Reed
JC
,
Ruoslahti
E
The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression
Proc Natl Acad Sci USA
1995
92
6161
6165
[PubMed]

The authors wish to acknowledge the excellent technical assistance of K. Mercer and D. Crowley for histology; M. Cummiskey and V. Evans for blastocyst injections; J. Trevithick for immunohistochemistry and P. Reilly for electron microscopy (all from Massachusetts Institute of Technology, Cambridge, MA). We thank A. Chung for the anti-entactin antibody. We are grateful to M. DiPersio and R. Chiquet-Ehrismann for critical reading of the manuscript and B. Bader for helpful discussion.

D. Taverna was supported by Swiss National Foundation, Ciba Geigy Foundation and European Molecular Biology Organization. R.O. Hynes is a Howard Hughes Medical Institute Investigator. This work was supported by the Howard Hughes Medical Institute, by a Program of Excellence (POE) grant (PO1 HL41484) from the National Heart, Lung and Blood Institute and by grants from the Muscular Dystrophy Association and the Department of Veterans Affairs (RAG 9502-010) to T.A. Rando.

Author notes

Address correspondence to R. Hynes, Massachusetts Institute of Technology, 77 Massachusetts Ave., E17-227, Cambridge, MA 02139. Tel.: (617) 253-6422. Fax: (617) 253-8357. E-mail: rohynes@mit.edu